Autocrine secretion-activated interleukin-6 (IL-6) in chronic lymphocytic leukemia (CLL) cells upregulates miR-19a, which disrupts toll-like receptor-7 (TLR-7) signaling [15]. This evidence concerns the gene IL6 and B-cell chronic lymphocytic leukemia.